The laboratory activities will be focused on providing comprehensive solutions and developing local guideline formulations in-line with current market trends
The import of formulations without registering technical or otherwise should be stopped to encourage Indian manufacturers
Around the world, these solutions are proving their worth for the company's customers in some 500 reference plants worldwide
Company's net profit reached €273 million in Q3 2021, 55% higher than versus Q3 2020
Company once again raised its full-year forecast and now expects sales of around €6 billion for full-year 2021
The company has reported total income of Rs. 1689.78 crores during the period ended September 30, 2021.
The net profit was at Rs 170.13 crore for the 6 months period ended September 30, 2021.
The company registered total income of Rs 539 crore for the quarter ended September 30, 2021.
The company' posted total income of Rs 071.32 crore for the period ended September 30, 2021.
The transaction includes technologies, intellectual property and trademarks and is expected to be completed by the end of 2021
2021 outlook for sales raised to between €76 billion and €78 billion and for EBIT before special items to between €7.5 billion and €8.0 billion
Income from operations for the Basic Chemistry Products at Rs. 2,235 crore was up by 22% and Specialty Products at Rs. 786 crore was up by 3%
LANXESS also relies on sustainable raw materials for its Durethan brand polyamide-6 plastics
The transaction is expected to close in the first half of 2022 after the necessary regulatory and antitrust approvals have been granted.
Company reported consolidated sales revenue of ¥1,325.2 billion, an increase of ¥278.4 billion year on year during H1 2021
New technology allows up to 15% higher cumulative methanol production
Third quarter 2021 sales from continuing operations increased by 23 % in local currency to CHF 1.096 billion
On completion of the acquisition, Synthomer will build on its significant portfolio and geographic growth alongside the diversification of its portfolio, end-markets and geographies with this new and highly complementary growth opportunity
The expansion plan of Epichlorohydrin (50 KTPA), CPVC (30 KTPA), Caustic Soda (106 KTPA) and CPP (36 MW) are going as per schedule
The Kiln has been lit up from yesterday.
Subscribe to our newsletter & stay updated.
_195_291.jpg)
